Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip Arthroscopy
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The study is a randomized placebo controlled trial to determine whether repeated
postoperative prophylactic ondansetron ("Zofran") administration will prevent postoperative
and/or postdischarge nausea and vomiting in patients undergoing ambulatory hip arthroscopy.
Ondansetron will be administered in the intra- and post-operative period. These individuals
will be followed on postoperative days 1, 2, and 3. It is hypothesized that the incidence of
postdischarge nausea and vomiting (PDNV) will be significantly decreased by postoperative
prophylactic administration of multiple doses of ondansetron (Zofran).